Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Delia Porto-Gonzalez"'
Autor:
Vicente Verez-Bencomo, Kalet Leon-Monzon, Yaima Zuniga-Rosales, Yanet Jerez-Barcelo, Yury Valdés-Balbín, Carmen Valenzuela-Silva, Marianniz Diaz-Hernandez, Yanet Climent-Ruiz, Juliet Enriquez-Puertas, Maria de los A. Garcia-Garcia, Delia Porto-Gonzalez, Raul Gonzalez-Mugica, Dagmar García-Rivera, Belinda Sanchez-Ramirez, Rocmira Perez-Nicado, Guang-Wu Chen, Pedro Pablo Guerra-Chaviano, Luis Herrera Martinez, Mireida Rodriguez-Acosta, Arturo Chang-Monteagudo, Tays Hernandez-Garcia, Rolando Ochoa-Azze, Rinaldo Puga-Gomez, Luis Dairon Rodríguez-Prieto, Ivette Orosa-Vazquez, Laura Ruiz-Villegas, Yenisey Triana-Marrero, Enrique Noa-Romero, Beatriz Marcheco-Teruel, Consuelo Macías-Abraham, Laura M. Rodríguez-Noda
We evaluated response to a single dose of the FINLAY-FR-1A recombinant dimeric-RBD base vaccine during a phase I clinical trial with 30 COVID-19 convalescents, to test its capacity for boosting natural immunity. This short report shows: a) an excelle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49b54584eb53e0bda49ce6494529dce
https://doi.org/10.1101/2021.02.22.21252091
https://doi.org/10.1101/2021.02.22.21252091
Autor:
Delia Porto-Gonzalez, Dagmar García-Rivera, Laura M. Rodríguez-Noda, Marianniz Diaz-Hernandez, Yanet Climent-Ruiz, Vicente Verez-Bencomo, Mireida Rodriguez-Acosta, Enrique Noa-Romero, Belinda Sanchez-Ramirez, Arturo Chang-Monteagudo, Pedro Pablo Guerra-Chaviano, Rolando Ochoa-Azze, Carmen Valenzuela-Silva, Olivia Fernández-Medina, Anet Valdes-Zayas, Yanet Jerez-Barcelo, Tays Hernandez-Garcia, Rocmira Perez-Nicado, Beatriz Marcheco-Teruel, Yenisey Triana-Marrero, Guang-Wu Chen, Laura Ruiz-Villegas, Rinaldo Puga-Gomez, Luis Dairon Rodríguez-Prieto, Maria de los A. Garcia-Garcia, Consuelo Macías-Abraham, Yury Valdés-Balbín, Juliet Enriquez-Puertas, Ivette Orosa-Vazquez, Yaíma Zúñiga-Rosales, Luis Herrera-Martínez
Publikováno v:
The Lancet Regional Health. Americas, Vol 4, Iss, Pp 100079-(2021)
Lancet Regional Health. Americas
Lancet Regional Health. Americas
Background: As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods: Thirty COVID-19 convalescents aged 22-57 years were studied: convalescents of mild COVID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469c1a80321831634d0a584123ac6c00
https://doi.org/10.1016/j.lana.2021.100079
https://doi.org/10.1016/j.lana.2021.100079
Autor:
Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los Ángeles García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Dairon Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Olivia Fernández-Medina, Anet Valdés-Zayas, Guang-Wu Chen, Luís Herrera-Martínez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo
Publikováno v:
The Lancet Regional Health. Americas, Vol 4, Iss , Pp 100079- (2021)
Background: As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods: Thirty COVID-19 convalescents aged 22-57 years were studied: convalescents of mild COVID
Externí odkaz:
https://doaj.org/article/54ac04bcc70849c995125a973cce9fdb